cucuvet
Account Basket
Store registered in the EU
Shipping to 25+ countries
+9.000 veterinary products
Secure payment

Tabernil spray tetramethrin-piperonyl butoxide 750ml

TABERNIL SPRAY TETRAMETHRIN – PIPERONYL BUOXIDE

36,54 €

Leave the EU in 24 hoursEU certified product30 return days

Description

TABERNIL SPRAY TETRAMETHRIN – PIPERONYL BUOXIDE

TECHNICAL SHEET (SUMMARY OF PRODUCT CHARACTERISTICS)
1. NAME OF THE VETERINARY MEDICINAL PRODUCT

TABERNIL SPRAY TETRAMETHRIN – PIPERONYL BUOXIDE

QUALITATIVE AND QUANTITATIVE COMPOSITION

Each gram contains:
Active substances:
Tetramethrin (20:80) 1,5mg

Piperonyl butoxide 8mg
Excipients, cs

For the full list of excipients, see section 6.1.

PHARMACEUTICAL FORM

Skin spray solution.

  1. CLINICAL DATA
    4.1 Target species

Canaries and ornamental birds.
4.2

Indications for use, specifying the target species

Treatment and prevention of ectoparasitosis of canaries and ornamental birds.

4.3

Contraindications

None.

4.4

Special warnings for each target species

Shake it before using.
Avoid its application on eyes and mucous membranes.
4.5 Special precautions for use
This medicinal product does not contain any antimicrobial preservatives.
Special precautions for use in animals
Pyrethrins are dangerous to fish. Avoid using near aquariums.
Special precautions to be taken by the person administering the medicinal product
veterinarian to the animals
Do not spray on a flame or incandescent body.
Pressure container.
Do not expose it to the sun or to temperatures above 45ºC.
Stay away from any source of ignition.
People with known hypersensitivity to pyrethroids should avoid all contact with the product.
veterinary drug.
Contact with the skin, mucous membranes and eyes should be avoided. In case of contact with skin, wash
immediately with soap and water. In case of contact with eyes, rinse immediately with
abundant water.
If due to incorrect use or accidental poisoning, consult with a
doctor immediately and show him the package leaflet or label.
Do not eat, smoke or drink during use.
Wash hands after administering the drug to animals.

4.6

Adverse reactions (frequency and seriousness)

They have not been described.
4.7

Use during pregnancy, lactation or lay

Contraindications have not been described during these periods.

 

4.8

Interaction with other medicinal products and other forms of interaction

Esterase and oxidase inhibitors (such as organophosphate insecticides) potentiate
its action by decreasing detoxification.
4.9

Dosage and route of administration

Cutaneous use.
Administration by spraying: press on the animal's body for a few
seconds keeping the aerosol bottle about 50 cm away from the animal to be treated. Repeat
every 5 days

.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Due to the form of application, it is unlikely that an overdose will occur.
Symptoms of poisoning are excitement and convulsions progressing to paralysis and
muscular fibrillation, which can cause death due to respiratory failure.
4.11 Timeout
Not applicable.
5. PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group: Ectoparasiticides, insecticides and repellents; combinations of
pyrethrins.
ATCVet code: QP53AC30
5.1 Pharmacodynamic properties
Tetramethrin is a synthetic type I pyrethroid. Type I pyrethroids (which do not contain a
alpha-cyano group) cause a pronounced increase in repetitive activity in the organs and
sensory nerve fibers. They act directly by affecting sodium channels in the
nerve membrane and cause a prolongation of the transient increase in permeability
to membrane sodium during excitation.
Type I pyrethroids also cause moderate presynaptic repetitive activity.
They produce excitement, convulsion, paralysis and death of the parasite.
Piperonyl butoxide is a synergizer for the action of tetramethrin; "per se" has a
little, almost zero, insecticidal power. When associated with tetramethrin or other pyrethrins, it increases the
their speed of action. The synergizing effect occurs by preventing the insect from degrading
tetramethrin, which increases the contact of the insecticide with the ectoparasite.
The association is active against: flies, mosquitoes, lice, ticks and mites.

5.2

Pharmacokinetic data

After administration via the skin, it minimally crosses intact skin. In the case of the
tetramethrin, can be absorbed in the gastrointestinal tract, absorption being enhanced if it is
associated with an oil-based vehicle.
 

 

  1. PHARMACEUTICAL DATA
    6.1 List of excipients

Isopropyl alcohol
methyl ethyl ketone
Glycerol
boreal perfume
Butane (aerosol grade mix)

6.2

Incompatibilities

None known.

6.3

Period of validity

Shelf life of the veterinary medicinal product packaged for sale: 3 years.
6.4 Special precautions for storage
This veterinary medicinal product does not require special storage conditions,
exception of those applicable to pressurized containers with liquefied gas which are:
Keep protected from direct sunlight or sources of ignition, do not expose it to temperatures
above 45ºC.
Keep away from foodstuffs, beverages and feed.
6.5 Nature and composition of immediate packaging
Tin plate pressure container, with polypropylene stopper, continuous type valve (Buna joint) and
high density polyethylene diffuser.
Formats:
210 ml pressure container: Contains: net volume 150 ml. Net Weight: 92,18g.
520 ml pressure container: Contains: net volume 400 ml. Net Weight: 245,81g.
1000 ml pressure container: Contains: net volume 750 ml. Net Weight: 460,9g.

6.6 Special precautions for disposal of the veterinary medicinal product
used or, where appropriate, the residues derived from its use

Any unused veterinary medicinal product or residues derived from it must be
disposed of in accordance with local regulations.
TABERNIL SPRAY TETRAMETHRIN – PIPERONYL BUOXIDE should not enter into
contact with water courses since it could be dangerous for fish and other
aquatic organisms.
Do not pierce the container or throw it into a fire, even empty.
7. MARKETING AUTHORIZATION HOLDER
DIVASA – FARMAVIC SA
Ctra. Sant Hipòlit, km 71 – 08503 GURB – VIC (Barcelona)
8. MARKETING AUTHORIZATION NUMBER
358 ESP
9. DATE OF THE FIRST AUTHORIZATION / RENEWAL OF THE AUTHORIZATION
Date of first authorization: May 28, 1992
Last renewal date: June 17, 2013
10. DATE OF REVISION OF THE TEXT
17 June, 2013
PROHIBITION OF SALE, DISPENSATION AND/OR USE
Dispensing conditions: Medicine not subject to veterinary prescription.

See technical sheet

Customer Reviews

0 reviews
0
0
0
0
0

Not yet reviewed

Only registered users who have purchased this product may make a review.

Menu
Wishlist
0 items Cart